MedTrace Logo

Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision

NCT02817321 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2019-01-08

No results posted yet for this study

Summary

This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. single-injection TPVB +continuous(pulsatile infusion) TPVB and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Conditions

  • Hepatectomy
  • Analgesia
  • Nerve Block

Interventions

PROCEDURE

single-injection TPVB + continuous TPVB

Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.

DEVICE

Philip CX50 Ultrasound Scanner

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning

DEVICE

PAJUNK Contiplex S Catheter

DRUG

single dose ropivacaine

* 2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total * given immediately after the correct position of the tip of the needle has been confirmed

DRUG

continuously infusion of ropivacaine

* 0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes * given through the catheter inserted in the T8 paravertebral space following the single dose

DRUG

Morphine given as IPCA

bolus: 2mg, lock time: 10min, 1h limitation: 8mg

Sponsors & Collaborators

  • Cui Xulei

    lead OTHER

Principal Investigators

  • Yuguang Huang, MD. · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-10-31
Completion
2018-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02817321 on ClinicalTrials.gov